1. Home
  2. APRE vs GTIM Comparison

APRE vs GTIM Comparison

Compare APRE & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.73

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Logo Good Times Restaurants Inc.

GTIM

Good Times Restaurants Inc.

HOLD

Current Price

$1.28

Market Cap

13.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
APRE
GTIM
Founded
2006
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
13.7M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
APRE
GTIM
Price
$0.73
$1.28
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.10
N/A
AVG Volume (30 Days)
125.6K
23.5K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
21.22
N/A
EPS
N/A
0.03
Revenue
N/A
$142,315,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$42.67
Revenue Growth
N/A
3.01
52 Week Low
$0.55
$1.10
52 Week High
$2.22
$2.09

Technical Indicators

Market Signals
Indicator
APRE
GTIM
Relative Strength Index (RSI) 38.93 45.86
Support Level $0.57 $1.24
Resistance Level $0.81 $1.29
Average True Range (ATR) 0.06 0.03
MACD -0.02 -0.00
Stochastic Oscillator 15.05 11.11

Price Performance

Historical Comparison
APRE
GTIM

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

About GTIM Good Times Restaurants Inc.

Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.

Share on Social Networks: